The WHO on Friday announced “it had delivered the first doses of H1N1 [swine flu] vaccine to Cuba, and a dozen countries in Africa would receive millions of doses in coming weeks,” Reuters reports. According to WHO spokeswoman Karen Mah, Cuba received an estimated 1.1 million doses Wednesday, and Honduras and El Salvador shipments are “en route,” according to the news service.
Pneumonia & Flu
Opinions: Discrimination Against Sexual Orientation; WFP In Somalia; Haiti’s Recovery; WHO’s Policy Role
Discrimination Against Sexual Orientation Are ‘Backward Steps’ For Human Rights In Africa In a Washington Post opinion piece, Desmond Tutu, archbishop emeritus of Cape Town, South Africa,Â and Nobel Peace Prize recipient,Â speaks out against efforts to deny individuals “their fundamental rights and freedoms” based on their sexual orientation. Tutu citesÂ cases in…
Study Finds Pfizer’s Pneumonia, Meningitis Vaccine Protects Against Recurrent Pneumonia In HIV Patients
Pfizer’s Prevnar 7 vaccine, which protects against pneumonia and meningitis, has been shown to reduce the risk of recurrent pneumococcal infection in patients living with HIV in Malawai, according to a study published Thursday in the New England Journal of Medicine, Reuters reports.
Also In Global Health News: Maternal, Child Health In Rwanda, Pakistan, India; Mongolia Weather; H1N1
Rwanda Targets Communities In Effort To Curb Maternal Mortality To reduce maternal mortality in Rwanda and reach U.N. Millennium Development Goal targets, the government will conduct maternal death audits in villages to help identify ways to improve outcomes, Rwanda’s Minister of Health Richard Sezibera announced recently, the New Times/allAfrica.com reports.…
New Pneumonia, Meningitis Vaccine Approved In U.S.; Pfizer, GAVI Will Lower Price In Developing Countries
The FDA approved Prevnar 13 â€“ a “new version of a blockbuster vaccine that fights pneumonia, meningitis and other infections” â€“ for use in children up to age five in the U.S., Reuters reports (Richwine, 2/24).
The WHO’s emergency committee concluded Tuesday that it was too early to declare that H1N1 (swine flu) has peaked in all parts of the world, the Associated Press reports. The announcement came after the committee met to review the most recent statistics H1N1 activity around the world (2/24).
The U.S. Food and Drug Administration (FDA) on Monday recommended that the H1N1 (swine flu) strain be added to next year’s seasonal flu vaccine, “putting an end to separate shots deployed against the pandemic,” Bloomberg reports. The FDA committee voted unanimously to make the H1N1 strain one of the three strains included in the shot, according to the news service. “The panelâ€™s recommendations are routinely adopted and used to guide vaccine manufacturers,” Bloomberg writes (Randall, 2/22).
The WHO is recommending the H1N1 (swine flu) virus be added to the regular flu vaccine for the Northern Hemisphere’s 2010-2011 regular flu season, the Associated Press reports (2/18).
Lancet Comment Examines Interconnectedness Of Global Health, Public Health “Global health and public health are indistinguishable,” according to a Lancet Comment that examines the interconnectedness of the fields. “Yet global health is still often perceived as international aid, technologies, and interventions flowing from the wealthier countries of the global north…
The WHO will convene a meeting of its emergency committee later this month to assess whether H1N1 (swine flu) has peaked, Keiji Fukuda, the special adviser to the WHO’s director general for pandemic influenza said Thursday, Bloomberg reports. “While the flu continues to spread in parts of the world, notably northern Africa, eastern Europe and eastern Asia, infection activity is declining, [Fukuda] said,” according to Bloomberg (Serafino, 2/11).